A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Intervention/treatment:
ASTEGOLIMAB
Medical condition:
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Protocol code:
GB43374
Control number:
275544
Status:
Recruiting
Approved:
June 22, 2023
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT05878769
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
40 Years to 90 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Reference Study ID Number: GB43374 https://forpatients.roche.com/ No attachments to email below.
Role
CONTACT
Phone:
888-662-6728
Name
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Role
CONTACT
Sponsor
HOFFMANN-LA ROCHE LIMITED

Locations

Alberta

Centre Hospitalier de l'Universite Laval
Québec, Alberta, G1V 4G5
RECRUITING
Edmonton Respiratory Consultants
Edmonton, Alberta, T5J 3S9
RECRUITING
Synergy Respiratory & Cardiac Care - Synergy Wellness Centre Location
Sherwood Park, Alberta, T8H 0N2
RECRUITING

British Columbia

Vancouver General Hospital
Vancouver, British Columbia, V5Z 1L8
RECRUITING

Ontario

Bluewater Clinical Research Group
Sarnia, Ontario, N7T 4X3
RECRUITING
Burlington Lung Clinic
Burlington, Ontario, L7N 3V2
RECRUITING
Dr. Syed Anees Medicine Profession Corporation
Windsor, Ontario, N8X 1T3
RECRUITING
Dr Anil Dhar Professional Medicine Corporation
Windsor, Ontario, N8X 5A6
RECRUITING
Dynamic Drug Advancement Ltd.
Ajax, Ontario, L1S 2J5
RECRUITING
Inspiration Research
Toronto, Ontario, M5T 3A9
RECRUITING

Quebec

Clinique de pneumologie et du sommeil de Lanaudiere
Saint-Charles-Borromée, Quebec, J6E 2B4
RECRUITING

Saskatchewan

University of Saskatchewan
Saskatoon, Saskatchewan, S7N 5A2
RECRUITING
Did you find what you were looking for?